October 09, 2025 (MLN): Macter International Limited (PSX: MACTER) obtained the requisite licenses for its Pre-Filled Syringe (PFS) and Pre-Filled Pen (PFP) manufacturing facilities within its Biotech area.
With these approvals, the company now has the capability to manufacture all three injectable biotechnology dosage forms Vials, Pre-Filled Syringes, and Pre-Filled Pens.
This milestone enables Macter to introduce advanced biotechnological products that offer greater therapeutic benefits and convenience for patients.